149 related articles for article (PubMed ID: 36149725)
1. Radiochemical Quality Control Methods for Radium-223 and Thorium-227 Radiotherapies.
Hasson A; Jiang W; Benabdallah N; Lu P; Longtine MS; Beattie BJ; Summer L; Zhang H; Wahl RL; Abou DS; Thorek DLJ
Cancer Biother Radiopharm; 2023 Feb; 38(1):15-25. PubMed ID: 36149725
[No Abstract] [Full Text] [Related]
2. Development of separation technology for the removal of radium-223 from targeted thorium conjugate formulations. Part I: purification of decayed thorium-227 on cation exchange columns.
Frenvik JO; Dyrstad K; Kristensen S; Ryan OB
Drug Dev Ind Pharm; 2017 Feb; 43(2):225-233. PubMed ID: 27628177
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of Thorium-227/Radium-223 Gamma-Camera Imaging During Radionuclide Therapy.
Larsson E; Brolin G; Cleton A; Ohlsson T; Lindén O; Hindorf C
Cancer Biother Radiopharm; 2020 Sep; 35(7):540-548. PubMed ID: 32486837
[TBL] [Abstract][Full Text] [Related]
4. Development of separation technology for the removal of radium-223 from decayed thorium-227 in drug formulations. Material screening and method development.
Frenvik JO; Kristensen S; Ryan OB
Drug Dev Ind Pharm; 2016 Aug; 42(8):1215-24. PubMed ID: 26569601
[TBL] [Abstract][Full Text] [Related]
5. Development of separation technology for the removal of radium-223 from targeted thorium conjugate formulations. Part II: purification of targeted thorium conjugates on cation exchange columns.
Frenvik JO; Dyrstad K; Kristensen S; Ryan OB
Drug Dev Ind Pharm; 2017 Sep; 43(9):1440-1449. PubMed ID: 28402142
[TBL] [Abstract][Full Text] [Related]
6. Determination of radionuclides and radiochemical impurities produced by in-house cyclotron irradiation and subsequent radiosynthesis of PET tracers.
Ishiwata K; Hayashi K; Sakai M; Kawauchi S; Hasegawa H; Toyohara J
Ann Nucl Med; 2017 Jan; 31(1):84-92. PubMed ID: 27744544
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Candidate Theranostics for
Abou DS; Longtine M; Fears A; Benabdallah N; Unnerstall R; Johnston H; Shim K; Hasson A; Zhang H; Ulmert D; Mangin F; Ozen S; Raibaut L; Brandès S; Meyer M; Chambron JC; Tatum DS; Magda D; Wahl RL; Thorek DLJ
J Nucl Med; 2023 Jul; 64(7):1062-1068. PubMed ID: 37142300
[No Abstract] [Full Text] [Related]
8. An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in Targeted Alpha Therapy (TAT).
Baimukhanova A; Engudar G; Marinov G; Kurakina E; Dadakhanov J; Karaivanov D; Yang H; Ramogida CF; Schaffer P; Magomedbekov EP; Filosofov D; Radchenko V
Nucl Med Biol; 2022; 112-113():35-43. PubMed ID: 35797877
[TBL] [Abstract][Full Text] [Related]
9. Practical considerations for quantitative clinical SPECT/CT imaging of alpha particle emitting radioisotopes.
Benabdallah N; Scheve W; Dunn N; Silvestros D; Schelker P; Abou D; Jammalamadaka U; Laforest R; Li Z; Liu J; Ballard DH; Maughan NM; Gay H; Baumann BC; Hobbs RF; Rogers B; Iravani A; Jha AK; Dehdashti F; Thorek DLJ
Theranostics; 2021; 11(20):9721-9737. PubMed ID: 34815780
[No Abstract] [Full Text] [Related]
10. Targeted Alpha Therapy with Thorium-227.
Frantellizzi V; Cosma L; Brunotti G; Pani A; Spanu A; Nuvoli S; De Cristofaro F; Civitelli L; De Vincentis G
Cancer Biother Radiopharm; 2020 Aug; 35(6):437-445. PubMed ID: 31967907
[TBL] [Abstract][Full Text] [Related]
11. Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators.
Kozempel J; Mokhodoeva O; Vlk M
Molecules; 2018 Mar; 23(3):. PubMed ID: 29510568
[TBL] [Abstract][Full Text] [Related]
12. Radiochemical separation of
Pruszyński M; Walczak R; Rodak M; Bruchertseifer F; Morgenstern A; Bilewicz A
Appl Radiat Isot; 2021 Jun; 172():109655. PubMed ID: 33657491
[TBL] [Abstract][Full Text] [Related]
13. Navigating through the coordination preferences of heavy alkaline earth metals: Laying the foundations for
Franchi S; Madabeni A; Tosato M; Gentile S; Asti M; Orian L; Di Marco V
J Inorg Biochem; 2024 Jul; 256():112569. PubMed ID: 38701687
[TBL] [Abstract][Full Text] [Related]
14. Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy.
Hagemann UB; Wickstroem K; Hammer S; Bjerke RM; Zitzmann-Kolbe S; Ryan OB; Karlsson J; Scholz A; Hennekes H; Mumberg D; Cuthbertson AS
Cancer Biother Radiopharm; 2020 Sep; 35(7):497-510. PubMed ID: 32255671
[TBL] [Abstract][Full Text] [Related]
15. The potential radio-immunotherapeutic α-emitter
Collins SM; Keightley JD; Ivanov P; Arinc A; Fenwick AJ; Pearce AK
Appl Radiat Isot; 2019 Mar; 145():251-257. PubMed ID: 30686576
[TBL] [Abstract][Full Text] [Related]
16. Production of high-purity radium-223 from legacy actinium-beryllium neutron sources.
Soderquist CZ; McNamara BK; Fisher DR
Curr Radiopharm; 2012 Jul; 5(3):244-52. PubMed ID: 22697483
[TBL] [Abstract][Full Text] [Related]
17. Construction of a thorium/actinium generator at the Canadian Nuclear Laboratories.
Perron R; Gendron D; Causey PW
Appl Radiat Isot; 2020 Oct; 164():109262. PubMed ID: 32819503
[TBL] [Abstract][Full Text] [Related]
18. Ra-224 labeling of calcium carbonate microparticles for internal α-therapy: Preparation, stability, and biodistribution in mice.
Westrøm S; Malenge M; Jorstad IS; Napoli E; Bruland ØS; Bønsdorff TB; Larsen RH
J Labelled Comp Radiopharm; 2018 May; 61(6):472-486. PubMed ID: 29380410
[TBL] [Abstract][Full Text] [Related]
19. An improved method for radium-isotopes quartet determination by alpha-particle spectrometry by using
Pérez-Moreno SM; Gázquez MJ; Casas-Ruiz M; San Miguel EG; Bolívar JP
J Environ Radioact; 2019 Jan; 196():113-124. PubMed ID: 30447554
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the separation and purification of
Ivanov PI; Collins SM; van Es EM; García-Miranda M; Jerome SM; Russell BC
Appl Radiat Isot; 2017 Jun; 124():100-105. PubMed ID: 28363158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]